Marrow fibrosis in myelodysplastic syndromes - Its significance in the context of the WHO classification of disease and the International Prognostic Scoring System.

被引：0
|
作者：
Buesche, G
Ganser, A
Wilkens, L
Schlegelberger, B
Hecker, H
Georgii, A
Kreipe, HH
机构：
[1] Hannover Med Sch, Inst Pathol, Hannover, Germany
[2] Hannover Med Sch, Klin Hamatol & Onkol, Hannover, Germany
[3] Hannover Med Sch, Inst Zell & Mol Pathol, Hannover, Germany
[4] Hannover Med Sch, Inst Biometrie, Hannover, Germany
来源：
BLOOD | 2004年 / 104卷 / 11期
关键词：
D O I：
10.1182/blood.V104.11.1446.1446
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1446
引用
收藏
页码：405A / 405A
页数：1
相关论文
共 50 条
  • [41] Myelodysplastic syndrome at large tertiary care community hospital: Prognostic factors according to the International Scoring System.
    Jaiyesimi, I
    Friedline, J
    Mattson, J
    Davis, B
    Balasubramanian, M
    Al-Khalili, A
    Blue-Hindy, D
    Burdakin, J
    Decker, D
    Zakalik, D
    Neumann, K
    Wilner, F
    BLOOD, 1998, 92 (10) : 630A - 630A
  • [42] Is International Prognostic Scoring System (IPSS) still standard in predicting prognosis in patients with myelodysplastic syndrome? External validation of the WHO Classification-Based Prognostic Scoring System (WPSS) and comparison with IPSS
    Park, Min Jae
    Kim, Hee-Jin
    Kim, Sun-Hee
    Kim, Dong Hwan
    Kim, Seok Jin
    Jang, Jun Ho
    Kim, Kihyun
    Kim, Won Seog
    Jung, Chul Won
    EUROPEAN JOURNAL OF HAEMATOLOGY, 2008, 81 (05) : 364 - 373
  • [43] World Health Organization and International Prognostic Scoring System: The limitations of current classification systems in assessing prognosis and determining appropriate therapy in myelodysplastic syndromes
    Schiffer, Charles A.
    SEMINARS IN HEMATOLOGY, 2008, 45 (01) : 3 - 7
  • [44] High flow cytometric scores identify adverse prognostic subgroups within the revised international prognostic scoring system for myelodysplastic syndromes
    Alhan, Canan
    Westers, Theresia M.
    Cremers, Eline M. P.
    Cali, Claudia
    Witte, Birgit I.
    Ossenkoppele, Gert J.
    van de Loosdrecht, Arjan A.
    BRITISH JOURNAL OF HAEMATOLOGY, 2014, 167 (01) : 100 - 109
  • [45] Validation of the Molecular International Prognostic Scoring System in patients with myelodysplastic syndromes (vol 141, pg 1768, 2023)
    Kewan, T.
    Bahaj, W.
    Durmaz, A.
    BLOOD, 2024, 143 (18) : 1879 - 1879
  • [46] Real-World Validation of Molecular International Prognostic Scoring System (IPSS-M) for Myelodysplastic Syndromes
    Sauta, Elisabetta
    Robin, Marie
    Bersanelli, Matteo
    Travaglino, Erica
    Meggendorfer, Manja
    Zhao, Lin-Pierre
    Berrocal, Juan Carlos Caballero
    Maggioni, Giulia
    Tentori, Cristina Astrid
    Bernardi, Massimo
    Di Grazia, Carmen
    Vago, Luca
    Rivoli, Giulia
    Borin, Lorenza
    D'Amico, Saverio
    Ubezio, Marta
    Campagna, Alessia
    Russo, Antonio
    Mannina, Daniele
    Lanino, Luca
    Chiusolo, Patrizia
    Giaccone, Luisa
    Voso, Maria Teresa
    Riva, Marta
    Oliva, Esther Natalie
    Zampini, Matteo
    Riva, Elena
    Nibourel, Olivier
    Sala, Claudia
    Bicchieri, Marilena
    Bolli, Niccolo
    Rambaldi, Alessandro
    Passamonti, Francesco
    Savevski, Victor
    Santoro, Armando
    Germing, Ulrich
    Kordasti, Shahram
    Santini, Valeria
    Diez-Campelo, Maria
    Sanz, Guillermo
    Sole, Francesc
    Kern, Wolfgang
    Platzbecker, Uwe
    Ades, Lionel
    Fenaux, Pierre
    Haferlach, Torsten
    Gastone, Castellani
    Della Porta, Matteo G.
    BLOOD, 2022, 140 : 1121 - 1124
  • [47] VALIDATION OF THE REVISED INTERNATIONAL PROGNOSTIC SCORING SYSTEM AND TRANSPLANTATION RISK INDEX ON POSTTRANSPLANTATION OUTCOME IN PATIENTS WITH MYELODYSPLASTIC SYNDROMES
    Yahng, S.
    Jeon, Y. W.
    Yoon, J. H.
    Shin, S. H.
    Lee, S. E.
    Choi, Y. S.
    Kim, D. Y.
    Lee, J. H.
    Eom, K. S.
    Lee, S.
    Min, C. K.
    Kim, H. J.
    Lee, J. W.
    Lee, K. H.
    Min, W. S.
    Lee, J. H.
    Kim, Y. J.
    LEUKEMIA RESEARCH, 2015, 39 : S129 - S130
  • [48] Comparison of International Prognostic Scoring System (IPSS) and Revised IPSS (IPSS-R) in myelodysplastic syndromes (MDS).
    Mushtaq, Muhammad Umair
    Ali, Abdullah
    Morita, Kiyomi
    Pinheiro, Ronald
    Baig, Muhammad
    Raza, Azra
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)
  • [49] A Revised International Prognostic Scoring System of 3.5 Points Stratifies Patients with Myelodysplastic Syndromes into 2 Risk Categories
    Montoro, Maria Julia
    Ortega, Margarita
    Villacampa, Guillermo
    Bernal, Teresa
    Pomares, Helena
    Castera, Elvira Mora
    Vilorio, Laura
    Tormo, Mar
    Diaz-Beya, Marina
    Brayan, Merchan
    Jerez, Andres
    Rivero, Eugenia
    Lys, Maria Jose
    Carcel, Paula
    Bargay, Joan
    Ramos, Fernando
    Xicoy, Blanca
    Diez-Campelo, Maria
    Valcarcel, David
    BLOOD, 2020, 136
  • [50] CYTOGENETIC CATEGORIES OF MYELODYSPLASTIC SYNDROMES (MDS) ACCORDING TO REVISED INTERNATIONAL PROGNOSTIC SCORING SYSTEM (R-IPSS)
    Gritsaev, S.
    Martinkevitch, I.
    Petrova, E.
    Kostroma, I.
    Ivanova, M.
    Martinenko, L.
    Sergeev, A.
    Abdukkadirov, K.
    HAEMATOLOGICA, 2012, 97 : 578 - 578
12345